News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.
Grandson of Jonas Salk raises cash to find ‘genetic needles in the haystack’
Seattle gene-sequencing startup TwinStrand Biosciences raised $50 million in a Series B round, bringing its total funding to $70 million. The company, which spun out
New high-tech lab at Fred Hutch creates 3D maps of proteins to aid therapeutics and vaccine research
A new lab has launched at the Fred Hutchinson Cancer Research Center to facilitate the cryogenic electron microscopy (cryo-EM) technique, which uses extreme temperatures and
Prevencio links with Atlas Genomics to roll out AI-powered blood tests for heart disease
Prevencio, a Kirkland, Washington-based biotechnology company, will partner with Atlas Genomics’ molecular diagnostic laboratory in Seattle to support the commercial rollout of Prevencio’s HART blood
Medical device startup Nanodropper raises $1.4M for eye drop bottle adapter
Nanodropper, a medical device startup founded by University of Washington and Seattle University graduates, announced that it received $1.4 million in seed funding. The company’s
Meet the most innovative and inventive pharmaceutical companies of 2021
Three life science companies with ties to Seattle were named to Fortune’s list of the 2021 most innovative and inventive pharmaceutical companies, which highlights companies
Oxford continues life sciences expansion with $119M Seattle buy
A Seattle office building was acquired by Toronto-based Oxford Properties Group, which intends to convert it into a fully dedicated life science facility. The purchase
Bothell’s biotech real estate market stays hot with $53M campus sale
Partners Rialto Capital of Miami and SteelWave LLC have bought Bothell-based Highlands Campus Tech Centre, home to Seagen, a leading biotech company that reported a
UW spinout Icosavax raises $100M for vaccine development
Icosavax Inc., a biotech company focused on vaccine development, announced a $100M Series B investment round. Icosavax, a spinout from the University of Washington plans
Seattle biotech firm Impel NeuroPharma files for $75M IPO
Impel NeuroPharma (Impel), a Seattle-based biotech company led by Adrian Adams, has indicated the company plans to go public. According to GeekWire, Impel filed paperwork
Seattle biotech startup Outpace Bio raises $30M to fight cancer with custom-designed proteins
Outpace Bio, a biotech company based in Seattle, announced it has raised $30M in a Series A round, led by ARTIS Ventures and Lyell. Outpace,
Seattle biotech OncoResponse raises $40.6M to create antibody-based treatments for cancer
OncoResponse, a Seattle biotech company focused on developing antibodies to make immunotherapy treatments, announced a $40.6M Series C investment round. The additional founding, led by
Move over, Boston and San Francisco? Seattle tops list of fastest growing biotech hubs for job opportunities
According to a new JLL report titled, “Life Sciences Emerging Markets Index: Poised for a paradigm shift,” Seattle is the fastest growing area for life